Increased gastric and intestinal permeability in patients with Crohn's disease

American Journal of Gastroenterology

Volumn 92, Issue 10, 1997, Pages 1891-1896

  Wyatt, John ^a   Oberhuber, Georg ^b   Pongratz, Susanne ^a   Püspök, Andreas ^a   Moser, Gabriele ^a   Novacek, Gottfried ^a   Lochs, Herbert ^c   Vogelsang, Harald ^a,b  

^a Clinic of Internal Medicine IV   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LACTULOSE; MANNITOL; SUCROSE; SUGAR;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GASTROINTESTINAL ENDOSCOPY; GLUCOSE URINE LEVEL; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; INTESTINE MUCOSA PERMEABILITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STOMACH MUCOSA; URINARY EXCRETION;

ADOLESCENT; ADULT; AGED; BIOPSY, NEEDLE; CROHN DISEASE; DUODENUM; ENDOSCOPY, GASTROINTESTINAL; FEMALE; GASTRIC MUCOSA; HUMANS; INTESTINAL MUCOSA; LACTULOSE; MALE; MANNITOL; MIDDLE AGED; PERMEABILITY;

EID: 0030777331     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Cobden I, Rothwell J, Axon AT. Intestinal permeability and screening tests for coeliac disease. Gut 1980;21:512-8.
2. Pearson AD, Eastham EJ, Laker MF, et al. Intestinal permeability in children with Crohn's disease and coeliac disease. Br Med J Clin Res Ed 1982;285:20-1.
3. Ukabam SO, Clamp JR, Cooper BT. Abnormal small intestinal permeability to sugars in patients with Crohn's disease of the terminal ileum and colon. Digestion 1983;27:70-4.
4. Strobel S, Brydon WO, Ferguson A. Cellobiose/mannitol sugar permeability test complements biopsy histopathology in clinical investigation of the jejunum. Gut 1984;25:1241-6.
5. André F, André C, Emery Y, et al. Assessment of the lactulose-mannitol test in Crohn's disease. Gut 1988;29:511-5.
6. Hodges S, Ashmore SP, Patel HR, et al. Cellobiose:mannitol differential permeability in small bowel disease. Arch Dis Child 1989;64: 853-5.
7. Heuman R, Sjödahl R, Tagesson C. Passage of molecules through the wall of the gastrointestinal tract: Intestinal permeability to polyethyleneglycol 1 000 in patients with Crohn's disease. Acta Chir Scand 1982;148:281-4.
8. Magnusson KE, Sundqvist T, Sjödahl R, et al. Altered intestinal permeability to low-molecular-weight polyethyleneglycols (PEG 400) in patients with Crohn's disease. Acta Chir Scand 1983;149:323-7.
9. Jenkins RT, Goodacre RL, Rooney PJ, et al. Studies of intestinal permeability in inflammatory diseases using polyethylene glycol 400. Clin Biochem 1986;19:298-302.
10. Hollander D, Vadheim CM, Brettholz E, et al. Increased intestinal . permeability in patients with Crohn's disease and their relatives: A possible etiologic factor. Ann Intern Med 1986;105:883-5.
11. Olaison G, Leandersson P, Sjödahl R, et al. Intestinal permeability to polyethyleneglycol 600 in Crohn's disease: Perioperative determination in a defined segment of the small intestine. Gut 1988;29:196-9.
12. Olaison G, Sjödahl R, Leandersson P, et al. Abnormal intestinal permeability pattern in colonic Crohn's disease: Absorption of low molecular weight polyethylene glycols after oral or colonic load. Scand J Gastroenterol 1989;24:571-6.
13. Bjarnason I O'Morain C, Levi AJ, et al. Absorption of 51 chromium-labeled ethylenediaminetetraacetate in inflammatory bowel disease. Gastroenterology 1983;85:318-22.
14. Peled Y, Watz C, Gilat T. Measurement of intestinal permeability using 51Cr-EDTA. Am J Gastroenterol 1985;80:770-3.
15. O'Morain CA, Abelow AC, Chervu LR, et al. Chromium 51-ethylenediaminetetraacetate test: A useful test in the assessment of inflammatory bowel disease. J Lab Clin Med 1986;108:430-5.
16. Jenkins RT, Jones DB, Goodacre RL, et al. Reversibility of increased intestinal permeability to 51Cr-EDTA in patients with gastrointestinal inflammatory diseases. Am J Gastroenterol 1987;82:1159-64.
17. Ainsworth M, Eriksen J, Rasmussen JW, et al. Intestinal permeability of 51Cr-labelled ethylenediaminetetraacetic acid in patients with Crohn's disease and their healthy relatives. Scand J Gastroenterol 1989;24:993-8.
18. Adenis A, Colombel JF, Lecouffe P, et al. Increased pulmonary and intestinal permeability in Crohn's disease. Gut 1992;33:678-82.
19. Meddings JB, Sutherland LR, Byles NI, et al. Sucrose: A novel permeability marker for gastroduodenal disease. Gastroenterology 1993;104:1619-26.
20. Meddings JB, Kirk D, Olson ME. Noninvasive detection of nonsteroidal anti-inflammatory drug-induced gastropathy in dogs. Am J Vet Res 1995;56:977-81.
21. Sutherland LR, Verhoef M, Wallace JL, et al. A simple, non-invasive marker of gastric damage: Sucrose permeability. Lancet 1994;343: 998-1000.
22. Keshavarzian A, Fields JZ, Vaeth J, et al. The differing effects of acute and chronic alcohol on gastric and intestinal permeability. Am J Gastroenterol 1994;89:2205-11.
23. Malchow H, Ewe K, Brandes JW, et al. European Cooperative Crohn's Disease Study (ECCDS): Results of drug treatment. Gastroenterology 1984;86:249-66.
24. Best WR, Becktel JM, Singleton JW, et al. Development of a Crohn's disease activity index: National Cooperative Crohn's Disease Study. Gastroenterology 1976;70:439-44.
25. Wyatt J, Vogelsang H, Hübl W, et al. Intestinal permeability and the prediction of relapse in Crohn's disease. Lancet 1993;341:1437-9.
26. Nugent FW, Richmond M, Park SK. Crohn's disease of the duodenum. Gut 1977;18:115-20.
27. Haggit RC, Meissner WA. Crohn's disease of the upper gastrointestinal tract. Am J Clin Pathol 1973;59:613-22.
28. Lenaerts C, Roy CC, Vaillancourt M, et al. High incidence of upper gastrointestinal tract involvement in children with Crohn disease. Pediatrics 1989;83:777-81.
29. Mashako MN, Cezard JP, Navarro J, et al. Crohn's disease lesions in the upper gastrointestinal tract: Correlation between clinical, radiological, endoscopic, and histological features in adolescents and children. J Pediatr Gastroenterol Nutr 1989;8:442-6.
30. Alcántara M, Rodriguez R, Potenciano JL, et al. Endoscopic and bioptic findings in the upper gastrointestinal tract in patients with Crohn's disease. Endoscopy 1993;25:282-6.
31. Schmidt-Sommerfeld E, Kirschner BS, Stephens JK. Endoscopic and histologic findings in the upper gastrointestinal tract of children with Crohn's disease. J Pediatr Gastroenterol Nutr 1990;11:448-54.
32. Ruuska T, Vaajalahti P, Arajarvi P, et al. Prospective evaluation of upper gastrointestinal mucosal lesions in children with ulcerative colitis and Crohn's disease. J Pediatr Gastroenterol Nutr 1994;19:181-6.
33. Gryboski JD, Thayer WR, Gabrielson IW, et al. Disacchariduria in gastrointestinal disease. Gastroenterology 1963;45:633-7.
34. Dunne WT, Cooke WT, Allan RN. Enzymatic and morphometric evidence for Crohn's disease as a diffuse lesion of the gastrointestinal tract. Gut 1977;18:290-4.
35. Arvanitakis C. Abnormalities of jejunal mucosal enzymes in ulcerative colitis and Crohn's disease. Digestion 1979;19:259-66.
36. Bolin T, Heuman R, Sjödahl R, et al. Decreased lysophospholipase and increased phospholipase A2 activity in ileal mucosa from patients with Crohn's disease. Digestion 1984;29:55-9.
37. Jönsson KA, Bodemar G, Tagesson C, et al. Variation of disaccharidase activities in duodenal biopsy specimens. Scand J Gastroenterol 1986;21:51-4.
38. Lembcke B, Schneider H, Lankisch PG. Is the assay of disaccharidase activity in small bowel mucosal biopsy relevant for clinical gastroenterologists? Klin Wochenschr 1989;67:568-75.
39. Park RH, Duncan A, Russell RI. Hypolactasia and Crohn's disease: A myth. Am J Gastroenterol 1990;85:708-10.
40. Schmitz-Moormann P, Malchow H, Pittner PM. Endoscopic and bioptic study of the upper gastrointestinal tract in Crohn's disease patients. Pathol Res Pract 1985;179:377-87.